BARBARA WAWRYSZYN: Open Payments
NPI 1417563891 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 10 payments from 6 companies in 2025. Trend: 2023 $2,681 · 2024 $3,730 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $243 |
| Lilly USA, LLC | 2 | $240 |
| ABBVIE INC. | 3 | $156 |
| Neurocrine BioSciences, Inc. | 1 | $137 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Boston Scientific Corporation | 1 | $106 |
Products named: Leqembi, KISUNLA, INGREZZA, QULIPTA, AUSTEDO XR, General - DBS, VYALEV.
Industry payments across FL — which companies pay providers there.
